Rheumatology

Top Story

FDA approves Avsola, fourth Remicade biosimilar

December 6, 2019

AURORA study: Voclosporin safe, effective for lupus nephritis

December 6, 2019
Phase 3 results from the AURORA study demonstrated combining voclosporin with mycophenolate and low-dose corticosteroids was superior to standard care for treating…
Feature

Podcasts driving a revolution in rheumatology medical education

December 6, 2019
When journalist Ben Hammersley coined the word “podcast” in 2004, he was attempting to put a name to the phenomenon resulting from the timely convergence of…
Feature

Ibogaine treatment for opioid use disorder: What you need to know

December 5, 2019
Miami is one of the few places in the United States where researchers study ibogaine, an indole alkaloid found in the root bark of a West African shrub that has…
In the Journals

RA increases risk for CV disease, sleep apnea, venous thromboembolism

December 5, 2019
Patients with inflammatory bowel disease, type 1 diabetes and venous thromboembolism have an increased risk for rheumatoid arthritis, which in turn increases the risk…
More Headlines »
CME ABIM MOC

Ace the Case: A 78-Year-Old Man With Acute Onset of Right Ankle Pain and Swelling

There is no commercial support for this activity.

This educational activity will utilize a case study to discuss the diagnosis and management of a 78-year-old man…
More »
Video
Meeting News

Many patients with RA unsatisfied with disease state

June 4, 2019
More »
Resource Centers
American College of Rheumatology Annual Meeting

American College of Rheumatology Annual Meeting

CME ABIM MOC

3rd Annual Association of Women in Rheumatology National Conference: Immunology Bootcamp - Best Of!

This activity is supported by educational grants from AbbVie, Inc.; Amgen Inc.; Bristol-Myers Squibb; Genentech, Inc.; GlaxoSmithKline; Lilly USA, LLC; Merck & Co., Inc.; and Sanofi Genzyme and Regeneron Pharmaceuticals.

Immune-mediated inflammatory diseases (IMIDs) are a group of clinically heterogeneous disorders, including rheumatoid…
More »
Current Issues
View the Current Issue
Healio Rheumatology